VIEMED HEALTHCARE, INC. Proceeds from Lines of Credit
VIEMED HEALTHCARE, INC. (VMD) reported Proceeds from Lines of Credit of $13.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-03-04
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for the quarter ending 2025-12-31 was $0.00.
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for the quarter ending 2025-09-30 was $13.00M.
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for the quarter ending 2024-12-31 was $0.00.
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for the quarter ending 2024-09-30 was $0.00.
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for fiscal 2025 was $13.00M, a 333.33% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for fiscal 2024 was $3.00M, a 62.50% decline from fiscal 2023.
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for fiscal 2023 was $8.00M.
- VIEMED HEALTHCARE, INC. proceeds from lines of credit for fiscal 2022 was $0.00.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $13.00M derived: sum of 2 quarters · filed 2026-03-04 | $13.00M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.00M 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $3.00M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.00M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $3.00M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $8.00M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $8.00M 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $8.00M 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | $0.00 10-K · filed 2025-03-10 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |